Somasundaram Subramaniam, MD MS

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Exelixis
    Topic: 
    Cabozantinib
    Date added: 
    08/19/2022
Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference